Effect of H56-28 (Aptine) on catecholamine-induced arrhythmias and neuromuscular transmission in man.
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols / Q000494:pharmacology*; D000758:Anesthesia; D001794:Blood Pressure / Q000187:drug effects; D002395:Catecholamines / Q000037:antagonists & inhibitors*; D003521:Cyclopropanes / Q000494:pharmacology; D004837:Epinephrine / Q000037:antagonists & inhibitors; D006221:Halothane / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D009469:Neuromuscular Junction / Q000187:drug effects*; D009609:Nitrous Oxide; D013390:Succinylcholine / Q000037:antagonists & inhibitors; D013565:Sympatholytics / Q000494:pharmacology*; D009435:Synaptic Transmission / Q000187:drug effects*; D014241:Trichloroethylene / Q000494:pharmacology; D014403:Tubocurarine / Q000037:antagonists & inhibitors
D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D002395:Catecholamines; D003521:Cyclopropanes; D013565:Sympatholytics; D014241:Trichloroethylene; D013390:Succinylcholine; D009609:Nitrous Oxide; D006221:Halothane; D014403:Tubocurarine; D004837:Epinephrine